Fischer Medical Ventures Limited (FISCHER) — regulation 31 | 8 April 2026

StockFin.ai

Try Free

Shankar Varadharajan, promoter of Fischer Medical Ventures Limited, declared under SEBI Regulation 31(4) that no additional share encumbrances were made during FY2026 beyond previously disclosed transactions. The promoter group, including FMV Holdings Pte Ltd (Singapore) and Ravindran Govindan acting in concert, maintained existing shareholding positions without new pledges or encumbrances.

📄 View Original Announcement (PDF)

📊 Stock Analysis — FISCHER ✨ Ask AI About This

About Fischer Medical Ventures Limited (FISCHER)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹2,261.37 Cr P/E: 59.0

View full FISCHER stock details →

📡 Get AI alerts when FISCHER files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FISCHER — Free

💡 Ask AI about this filing

"How does this regulation 31 affect Fischer Medical Ventures Limited's outlook?" "What did Fischer Medical Ventures Limited announce on 8 April 2026?" "Is this positive or negative for FISCHER?"

Ask AI Free →

📊 More FISCHER filings

See all FISCHER filings →

🔥 Also filed on 8 April 2026

RGL Renaissance Global Limited Financial Results RISHABH Rishabh Instruments Limited Corporate Action RAIN Rain Industries Limited Announcement PVSL Popular Vehicles and Services Limited Announcement PRICOLLTD Pricol Limited Annual Report RKSWAMY R K Swamy Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when FISCHER files new disclosures

Track FISCHER filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FISCHER — Free

Free account · 2 AI queries/day